1h Free Analyst Time
The thrombosis drugs market is forecasted to grow by USD 17.01 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the thrombosis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of novel oral anticoagulants, growing prevalence of coagulation disorders, and growing awareness of cardiac care.
The thrombosis drugs market is segmented as below:
By Indication
- Pulmonary embolism
- DVT
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the thrombosis drugs market covers the following areas:
- Thrombosis drugs market sizing
- Thrombosis drugs market forecast
- Thrombosis drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The companies presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Indication
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global thrombosis drugs market: Aspen Pharmacare Holdings Ltd., AuroMedics Pharma LLC, Baxter International Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, GoodRx Holdings Inc., Grifols SA, Inari Medical Inc., Italfarmaco Holding SPA, Johnson and Johnson Services Inc., Pfizer Inc., Sanofi SA, Vasudha Pharma Chem Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is sedentary lifestyle."
According to the report, one of the major drivers for this market is the introduction of novel oral anticoagulants.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aspen Pharmacare Holdings Ltd.
- AuroMedics Pharma LLC
- Baxter International Inc.
- Bayer AG
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- GoodRx Holdings Inc.
- Grifols SA
- Inari Medical Inc.
- Italfarmaco Holding SPA
- Johnson and Johnson Services Inc.
- Pfizer Inc.
- Sanofi SA
- Vasudha Pharma Chem Ltd.
- Viatris Inc.
